Analyzing MariMed (OTC:MRMD) and Charlie’s (OTCMKTS:CHUCD)

MariMed (OTC:MRMDGet Free Report) and Charlie’s (OTCMKTS:CHUCDGet Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for MariMed and Charlie’s, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MariMed 0 0 0 1 4.00
Charlie’s 0 0 0 0 0.00

Earnings & Valuation

This table compares MariMed and Charlie’s”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MariMed $148.60 million 0.18 -$16.03 million ($0.03) -2.35
Charlie’s $16.69 million 1.22 -$7.19 million N/A N/A

Charlie’s has lower revenue, but higher earnings than MariMed.

Profitability

This table compares MariMed and Charlie’s’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MariMed -8.95% 1.58% 0.53%
Charlie’s -140.60% N/A -327.67%

Volatility and Risk

MariMed has a beta of 2.99, suggesting that its stock price is 199% more volatile than the S&P 500. Comparatively, Charlie’s has a beta of 5.57, suggesting that its stock price is 457% more volatile than the S&P 500.

Institutional and Insider Ownership

0.2% of MariMed shares are owned by institutional investors. Comparatively, 3.1% of Charlie’s shares are owned by institutional investors. 19.0% of MariMed shares are owned by company insiders. Comparatively, 74.8% of Charlie’s shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

MariMed beats Charlie’s on 6 of the 11 factors compared between the two stocks.

About MariMed

(Get Free Report)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

About Charlie’s

(Get Free Report)

Charlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes e-cigarette liquids and vaping systems in the United States and internationally. The company also offers energy drink under the Bazi brand name. It sells its products through distributors, specialty retailers, and third-party online resellers to approximately 80 countries, primarily, including the United Kingdom, Italy, Spain, Belgium, Australia, Sweden, and Canada. The company was formerly known as True Drinks Holdings, Inc. and changed its name to Charlie's Holdings, Inc. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.